Co-Diagnostics, Inc. Increase (Decrease) in Income Taxes Payable
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Income Taxes Payable of -$713.64 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-13
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$491.85K.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$245.09K, a 1294.66% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-06-30 was $11.81K, a 41.25% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-03-31 was $11.48K, a 42.09% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for fiscal 2025 was -$713.64K, a 1410.47% decline from fiscal 2024.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for fiscal 2024 was $54.46K.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for fiscal 2023 was -$522.10K.
- Co-Diagnostics, Inc. increase (decrease) in income taxes payable for fiscal 2022 was -$2.20M, a 183.27% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$491.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$736.93K derived: sum of 2 quarters · filed 2026-03-31 | -$725.13K derived: sum of 3 quarters · filed 2026-08-13 | -$713.64K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$245.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$233.28K derived: sum of 2 quarters · filed 2026-08-13 | -$221.79K 10-Q · filed 2025-11-13 | -$227.78K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $11.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $23.29K 10-Q · filed 2026-08-13 | $17.30K derived: sum of 3 quarters · filed 2026-08-13 | $37.82K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $11.48K 10-Q · filed 2026-05-14 | $5.50K derived: sum of 2 quarters · filed 2026-05-14 | $26.01K derived: sum of 3 quarters · filed 2026-05-14 | $46.11K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$5.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $14.53K derived: sum of 2 quarters · filed 2026-03-31 | $34.63K derived: sum of 3 quarters · filed 2026-03-31 | $54.46K 10-K · filed 2026-03-31 |
| 2024-09-30 | $20.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $40.61K derived: sum of 2 quarters · filed 2025-11-13 | $60.44K 10-Q · filed 2025-11-13 | -$640.10K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $20.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $39.93K 10-Q · filed 2025-08-14 | -$660.61K derived: sum of 3 quarters · filed 2025-08-14 | -$504.86K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $19.83K 10-Q · filed 2025-05-08 | -$680.71K derived: sum of 2 quarters · filed 2025-05-08 | -$524.96K derived: sum of 3 quarters · filed 2025-05-08 | -$514.06K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$700.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$544.79K derived: sum of 2 quarters · filed 2025-03-27 | -$533.89K derived: sum of 3 quarters · filed 2025-03-27 | -$522.10K 10-K · filed 2025-03-27 |
| 2023-09-30 | $155.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $166.65K derived: sum of 2 quarters · filed 2024-11-07 | $178.44K 10-Q · filed 2024-11-07 | -$199.83K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $10.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $22.69K 10-Q · filed 2024-08-08 | -$355.58K derived: sum of 3 quarters · filed 2024-08-08 | -$260.05K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $11.80K 10-Q · filed 2024-05-09 | -$366.48K derived: sum of 2 quarters · filed 2024-05-09 | -$270.94K derived: sum of 3 quarters · filed 2024-05-09 | -$4.94M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$378.27K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$282.74K derived: sum of 2 quarters · filed 2024-03-14 | -$4.95M derived: sum of 3 quarters · filed 2024-03-14 | -$2.20M 10-K · filed 2024-03-14 |
| 2022-09-30 | $95.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$4.57M derived: sum of 2 quarters · filed 2023-11-09 | -$1.82M 10-Q · filed 2023-11-09 | $127.58K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.92M 10-Q · filed 2023-08-10 | $32.05K derived: sum of 3 quarters · filed 2023-08-10 | $1.32M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.75M 10-Q · filed 2023-05-11 | $4.70M derived: sum of 2 quarters · filed 2023-05-11 | $5.98M derived: sum of 3 quarters · filed 2023-05-11 | $4.26M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.23M derived: sum of 2 quarters · filed 2023-03-16 | $1.51M derived: sum of 3 quarters · filed 2023-03-16 | $2.64M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$435.62K derived: sum of 2 quarters · filed 2022-11-10 | $692.82K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$590.38K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $1.13M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |